Kestra Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Buy
18,027
+141
+0.8% +$27.7K 0.01% 990
2026
Q1
$3.51M Hold
17,886
0.01% 982
2025
Q4
$3.1M Sell
17,886
-238
-1% -$43.3K 0.01% 974
2025
Q3
$3.45M Buy
18,124
+3,251
+22% +$577K 0.02% 878
2025
Q2
$2.67M Buy
14,873
+1,872
+14% +$325K 0.01% 934
2025
Q1
$2.2M Buy
13,001
+15
+0.1% +$2.46K 0.01% 942
2024
Q4
$1.96M Buy
12,986
+121
+0.9% +$18.8K 0.01% 1014
2024
Q3
$2M Sell
12,865
-439
-3% -$65.6K 0.01% 951
2024
Q2
$1.82M Buy
13,304
+540
+4% +$73.9K 0.01% 1009
2024
Q1
$1.7M Sell
12,764
-265
-2% -$34.4K 0.01% 956
2023
Q4
$1.8M Buy
13,029
+7,495
+135% +$985K 0.01% 842
2023
Q3
$674K Sell
5,534
-209
-4% -$27.8K 0.01% 1205
2023
Q2
$807K Sell
5,743
-1,928
-25% -$266K 0.01% 1080
2023
Q1
$1.09M Sell
7,671
-6,676
-47% -$955K 0.01% 910
2022
Q4
$2.24M Buy
14,347
+4,738
+49% +$681K 0.02% 701
2022
Q3
$1.18M Buy
9,609
+1,029
+12% +$136K 0.01% 893
2022
Q2
$1.14M Sell
8,580
-2,882
-25% -$393K 0.01% 913
2022
Q1
$1.57M Sell
11,462
-2,114
-16% -$295K 0.02% 763
2021
Q4
$2.35M Sell
13,576
-1,154
-8% -$176K 0.02% 629
2021
Q3
$2.14M Sell
14,730
-336
-2% -$49.2K 0.02% 679
2021
Q2
$1.99M Buy
15,066
+143
+1% +$18.7K 0.02% 658
2021
Q1
$1.92M Sell
14,923
-1,229
-8% -$151K 0.02% 616
2020
Q4
$1.91M Buy
16,152
+16,027
+12,822% +$1.95M 0.02% 609
2020
Q3
$956K Buy
+125
New +$14.8K 0.02% 631

Other funds holding DGX

Kestra Advisory Services's DGX Position: Q2 2026 in Review

Kestra Advisory Services increased its Quest Diagnostics (DGX) stake by 0.79% in Q2 2026, buying an estimated $27.7K and bringing the position to 18,027 shares worth $3.82M. The position accounts for 0.01% of the portfolio, ranked #990.

Kestra Advisory Services first reported a position in DGX in Q3 2020 and has held it in 24 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Kestra Advisory Services held 18,027 shares of Quest Diagnostics worth $3.82M as of Q2 2026.
  • Kestra Advisory Services bought 141 Quest Diagnostics shares in Q2 2026, an estimated $27.7K.
  • Quest Diagnostics made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #990 holding.
  • Kestra Advisory Services first reported a position in Quest Diagnostics in Q3 2020 and has held it in 24 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.